Search results
Results from the WOW.Com Content Network
Dexlansoprazole, is a medication which reduces stomach acid. [3] It is used to treat gastroesophageal reflux disease. [3] Effectiveness is similar to other proton pump inhibitors (PPIs). [4]
Vonoprazan, sold under the brand name Voquezna among others, is a first-in-class potassium-competitive acid blocker medication. [2] [1] Vonoprazan is used in form of the fumarate for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
Pages in category "Drugs developed by Takeda Pharmaceutical Company" The following 59 pages are in this category, out of 59 total. This list may not reflect recent changes .
Takeda's treatment will be available in stick packs of 2 milligram doses by the end of February, the company said. The company has set wholesale acquisition cost for the therapy, given twice daily ...
Abbott and Takeda agreed to end the partnership in 2008, with Abbott keeping the rights to leuprorelin, which had sales in 2007 of $600 million and a patent expiring in 2015 and the approximately 300 employees who worked on the product, and Takeda keeping the rights to lansoprazole, which had sales of $2.3 billion in 2007 but was facing ...
Under terms of the amendment, Takeda will pay Wave $22.5 million for collaboration-related research and preclinical expenses. The amendment allows Wave to advance or partner CNS programs ...
In August 2015, Shire Plc made an unsolicited $30.6 billion stock offer for the company [6] [7] increasing the Baxalta share price over 16%. Baxalta investors would be set to receive 0.1687 of Shire's American Depositary Receipts for every share they hold, representing a premium of 36%, compared to the company's stock price on August 3. [ 8 ]
Few if any of the hundreds of employees at the 15 facilities implementing the program are medical professionals, and because of this lack of a medical approach at the centers, the state doesn’t technically define what they offer as “treatment.” “We look at it as an education, self-help program,” said Mike Townsend, the head of ...